Innova tests’ performance not proven and they should be returned to manufacturer or thrown in bin, says FDA
- Coronavirus – latest updates
- See all our coronavirus coverage
The US Food and Drug Agency (FDA) has raised significant concerns about the rapid Covid test on which the UK government has based its multibillion-pound mass testing programme.
In a scathing review, the US health agency suggested the performance of the test had not been established, presenting a risk to health, and that the tests should be thrown in the bin or returned to the California-based manufacturer Innova.